RCEL
RCEL
NASDAQ · Biotechnology

Avita Medical Inc

$7.77
+3.02 (+63.58%)
As of Aug 9, 10:41 PM ET ·
Analyst Consensus
Buy
10
Analysts
Moderate
Coverage
Buy 7 70%
Hold 3 30%
Sell 0 0%
Price Target
Analyst Price Target +345.4% upside
Low Target $23.82
Average Target $34.61
High Target $34.97
Current Price $7.77
Current
$7.77
Target
$34.61
$23.82 $34.61 avg $34.97
Scenario Analysis
Bear Case
$23.82
206.6%
Low target
Base Case
$34.61
+345.4%
Avg target
Bull Case
$34.97
+350.1%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$7.12
9.1% from high
52-Week Low
$3.22
+141.3% from low
Target vs 52W High
$34.61
+386.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 +3.3%
AMGN
Amgen Inc
Hold 43 49% $190.87 -54.0%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -13.3%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.4%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -53.9%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.0%
BIIB
Biogen Inc
Buy 43 67% $91.45 -56.4%